List view / Grid view
15 April 2015 | By Daiichi Sankyo
Swissmedic has granted approval of Lixiana for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation...
15 April 2015 | By Victoria White
WHO has issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result...
15 April 2015 | By Victoria White
The U.S. Food and Drug Administration (FDA) has agreed to the proposed Phase 3 clinical development programme for Motif’s lead product candidate, iclaprim...
15 April 2015 | By Victoria White
The European Regulatory Authority has approved Omeros’ OMS721 for compassionate use in two patients with with thrombotic microangiopathy...
14 April 2015 | By Victoria White
Incyte's base for European clinical development operations is to be based in Geneva, Switzerland. Incyte is to occupy a 9,000 sq. ft. facility by mid-2015...
14 April 2015 | By Victoria White
Merck is introducing diabetes management training for more than 5,000 Maharashtra University students as part of the Merck Capacity Advancement Program...
14 April 2015 | By Victoria White
The Changing Diabetes in Children programme, a scheme that has provided free insulin to 13,000 children since 2009, has been extended by three years.
14 April 2015 | By Victoria
The NEFIGAN Trial of Nefecon for the treatment of primary IgA nephropathy has fully met its primary efficacy endpoint at a planned interim analysis...
14 April 2015 | By Victoria White
A new liver cancer treatment developed by the UMC Utrecht that uses uses radioactive holmium microspheres has received the European CE mark...
14 April 2015 | By Victoria White
Merck has announced that Udit Batra has been appointed to lead the combined life science business of Merck Millipore and Sigma-Aldrich...
13 April 2015 | By Victoria White
Ichor Medical Systems has announced that it has entered into a product development collaboration and worldwide license agreement with Janssen...
13 April 2015 | By Victoria White
The FDA has modified the partial clinical hold on the IND for TKM-Ebola to permit repeat dosing of healthy volunteers at a dose of 0.24 mg/kg/day...
13 April 2015 | By Victoria White
ReNeuron has announced that it has filed an Investigational New Drug (IND) application with the United States Food and Drug Administration (FDA) to commence a Phase I/II clinical trial with its human Retinal Progenitor Cell (hRPC) therapy candidate for retinitis pigmentosa (RP).
13 April 2015 | By Victoria White
ABIVAX, a biotechnology company developing first-in-class anti-viral drugs and vaccines, has announced publication of the mechanism of action of ABX464...
13 April 2015 | By Victoria White
Novo Nordisk has opened a manufacturing facility in the Kaluga region of Russia for formulation and filling of modern insulin for the treatment of diabetes...
